Back to Search
Start Over
Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders.
- Source :
-
NPJ vaccines [NPJ Vaccines] 2020 Oct 21; Vol. 5, pp. 99. Date of Electronic Publication: 2020 Oct 21 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Opioid use disorders (OUD) affect over 27 million people worldwide. Anti-opioid vaccines offer a promising strategy to treat OUD and prevent overdose. Using immunomodulation of cytokine signaling to increase vaccine efficacy, this study found that blocking IL-4 improved the efficacy of vaccines targeting oxycodone and fentanyl in male and female mice. Genetic deletion of the IL-4 receptor, STAT6, or antibody-based depletion of IL-13, did not increase vaccine efficacy against opioids, suggesting the involvement of type I IL-4 receptors. Enhancement of vaccine efficacy with blockade of IL-4 was associated with improved germinal center formation in secondary lymphoid organs and selective transcriptome signatures in the activated CD4 <superscript>+</superscript> T cell population subset. These data suggest that IL-4 is both a pharmacological target and a potential biomarker of vaccine efficacy against OUD.<br />Competing Interests: Competing interestsM.P. is the inventor of “Cytokine Signaling Immunomodulators and Methods”, and “fentanyl hapten-conjugates and methods for making and using same” patents. The anti-IL-13 mAb was obtained from Genentech under a standard Material Transfer Agreement. All authors declare that there are no other competing interests.<br /> (© The Author(s) 2020.)
Details
- Language :
- English
- ISSN :
- 2059-0105
- Volume :
- 5
- Database :
- MEDLINE
- Journal :
- NPJ vaccines
- Publication Type :
- Academic Journal
- Accession number :
- 33101712
- Full Text :
- https://doi.org/10.1038/s41541-020-00247-7